|
Volumn 13, Issue 5, 2007, Pages 443-447
|
Why current breast pathology practices must be evaluated. A Susan G. Komen for the Cure white paper: June 2006
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL MARKER;
TAMOXIFEN;
ARTICLE;
BREAST BIOPSY;
BREAST CANCER;
CANCER DIAGNOSIS;
CANCER PATIENT;
CANCER SURGERY;
CLINICAL PRACTICE;
DIAGNOSTIC ACCURACY;
EVALUATION RESEARCH;
HEALTH CARE QUALITY;
HEALTH INSURANCE;
HUMAN;
MAMMOGRAPHY;
PATIENT MONITORING;
REIMBURSEMENT;
STANDARDIZATION;
BREAST;
BREAST NEOPLASMS;
FEMALE;
HUMANS;
INSURANCE, HEALTH;
INSURANCE, HEALTH, REIMBURSEMENT;
PATHOLOGY;
TISSUE BANKS;
|
EID: 34548269898
PISSN: 1075122X
EISSN: 15244741
Source Type: Journal
DOI: 10.1111/j.1524-4741.2007.00463.x Document Type: Article |
Times cited : (24)
|
References (7)
|